With several minimally invasive options available, surgeons and patients are more focused than ever on reducing surgical trauma while maximizing cosmetic results.
We are committed to working tirelessly with our physician partners and health care providers to make the use of these new and innovative magnetic surgical platforms commonplace, so that together, we can make a difference in each patient’s quality of life.
Founder, President, CEO
Minimally invasive general surgeon with more than 10 years of clinical experience. Medical inventor with multiple patents and clinical researcher with publications in international journals, especially in the field of post-operatory pain.
Chief Operations Officer
Twenty-five years of product development and operations experience. Held leadership roles at Luma Therapeutics, Acclarent, Google, Google(x) and was a founding member of Verily Life Sciences (Google). BS and MS in Mechanical Engineering from Stanford University.
Chief Commercial Officer
Twenty-five years of sales and sales leadership experience at both large and small organizations. Held leadership roles at Boston Scientific, Acclarent – a Johnson and Johnson company, Spirox, and most recently Stryker ENT.
Vice President, Marketing
Twenty years of medical device marketing and sales experience. Led commercialization of new technologies at Acclarent, Kyphon, Cordis Cardiology and Ethicon Endo-Surgery. BS in Biology from Bucknell University and MBA from The Wharton School.
Senior Director, Operations
Twenty-five years of medical device engineering and operations experience. Held leadership roles in engineering and manufacturing at Heartport, Johnson & Johnson, Concentric Medical and Stryker Neurovascular. BS in Mechanical Engineering from The Ohio State University.
Executive level Regulatory Affairs and Clinical Research professional with over 30 years of experience and expertise. Former Senior Vice President/Vice President of Regulatory Affairs and Clinical Research for Conceptus and Kyphon.
Current President and CEO of Pulmonx Corporation. Over 30 years of general management, marketing, and sales experience in both large and small companies. Co-founded, built, and sold multiple medical device companies. Formerly President of Pulmonary Endoscopy and Boston Scientific Corporation, and CEO and Co-Founder of Asthmatx and Bronchus Technologies.
Current President and CEO of AirXpanders, Inc. Over 20 years of general management, marketing and business development experience in the medical device industry. Previously, President and CEO at MRI Interventions; Vice President, Marketing and New Business Development of Intuitive Surgical Inc.; Vice President, Marketing and Business Development of Kyphon and Vice President, Marketing at Boston Scientific Corporation.
Current Senior Vice President, Sales at Pulmonx Corporation. Over 30 years of experience in the medical device industry building high performing sales organizations. Formerly served as President and CEO of Carbylan Therapeutics and Neomend; EVP and CCO of SurgRx; EVP of Sales and Marketing at Novacept; and Worldwide VP of Marketing at C.R. Bard, IMPRA division.
Founder, President, CEO
Minimally invasive general surgeon with more than 10 years of clinical experience. Medical inventor with multiple patents and clinical researcher with publications in international journals, especially in the field of post-operative pain.
Current President and CEO of Aegea Medical. Over 25 years of experience in commercial and leadership positions in the medtech industry. Previously served as the President and CEO of Cardiokinetix, President and CEO of Concentric Medical, Inc., and President of the Cardiac Surgery division of Guidant Corporation.
Managing Partner at Aurus Capital focusing on early stage biotech, pharma, and medtech investments. Previously worked at Athelera LLC with responsibility for mergers and acquisitions in Latin America and Europe. Served as a consultant for the Boston Consulting Group.
The shaftless Levita System reduces the number of incisions and dedicated trocars for better cosmetic outcomes. The Levita System enables reduced-port laparoscopic techniques.
The Magnetic Surgical System is indicated in the U.S. to grasp and retract the body and the fundus of the gallbladder in laparoscopic cholecystectomy, the liver in bariatric procedures and the prostate and periprostatic tissue in prostatectomy procedures to facilitate access and visualization of the surgical site in patients with a BMI range of 20 to 60 kg/m2.